Sign in

CIK 0001347178

  • Accelerated filer

Vanda Pharmaceuticals Inc.

Sign in to watch
Ticker
VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
030491827
Phone
+1 202-734-3400
Business address
2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
Open-market buys, last 90 days
$38,094
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$38,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Duncan Charles Cliff +$38K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-02-28 Gulino Richard L. SVP, General Counsel & Sec. Grant or award · Employee Stock Option (Right to Buy) +70,000 70,000
2018-02-28 Birznieks Gunther SVP, Business Development Grant or award +30,000 148,366
2018-02-28 Birznieks Gunther SVP, Business Development Grant or award · Employee Stock Option (Right to Buy) +70,000 70,000
2018-01-02 Reverberi Gian Piero SVP & Chief Commercial Officer Option exercise +12,500 87,500
2018-01-02 Reverberi Gian Piero SVP & Chief Commercial Officer Option exercise +7,500 110,000
2018-01-02 Reverberi Gian Piero SVP & Chief Commercial Officer Option exercise · Restricted Stock Unit −12,500 25,000
2018-01-02 Reverberi Gian Piero SVP & Chief Commercial Officer Option exercise · Restricted Stock Unit −7,500 15,000

Page 20 of 20 · 387 trades